New York, NY, September 19, 2015 --(PR.com
)-- The Silverman Method for gender selection is the innovative technique that involves In Vitro Fertilization (IVF) and Pre-Implantation Genetic Diagnosis (PGD), created by Dr. Andrew Silverman. He further enhances this technique with the additional benefit of GSMART, an exclusive sperm-separation method.
Dr. Silverman’s GSMART Method is an effective, and non-invasive procedure that greatly increases the chances for successful gender selection. He combines sperm with human serum albumin (HSA), and then separates the sperm cells based on whether they carry the male or female chromosome. Then, only the sperm of the chosen gender are used for fertilization of the collected eggs.
Additionally, Dr. Silverman is the only specialist locally who successfully incorporates Transcutaneous Electrical Acupoint Stimulation (TEAS), into the gender selection process. He is also the only physician in the world who has incorporated it into non-IVF gender selection. TEAS, a form of acupressure treatment, stimulates specific acupoints before and after embryo transfer, which aids in implantation, nourishes the embryo, and increases pregnancy rates. A more detailed description of TEAS is included at the end of this press release. TEAS is included in the GSMART Method because it is an effective and safe way to increase the rate of successful pregnancies and gender selection.
The combination of these unique methods make up The Silverman Method, which Dr. Silverman has perfected to a near 100% success rate.
The Silverman Method is also recommended for couples concerned about passing on genetic diseases. During the IVF/PGD process, embryos are created from the sperm and eggs. The embryos are then analyzed to create a complete genetic profile so only healthy embryos of the preferred sex are transferred to the uterus. Even before Dr. Silverman’s unique enhancements, the IVF/PGD method had been recognized for offereing the highest success rates for gender selection.
In addition to its effectiveness, IVF with PGD can offer you added peace of mind with optional embryo testing for genetic diseases before implantation. Recent advances in genetically enhanced assisted reproductive technologies (ART), also known as reprogenetic technologies, now enable optional screenings for a variety of genetic mutations. These include, but are not limited to, BRCA1 and BRCA2 that could prevent genetic conditions including cystic fibrosis, Duchenne muscular dystrophy, hemophilia, sickle cell disease, Tay-Sachs disease, breast and ovarian cancers, and many others.
Transcutaneous Electrical Acupoint Simulation (TEAS)
This is an acupuncture-like procedure that has been scientifically shown to increase pregnancy rates. Unlike traditional acupuncture, TEAS does not involve needles. Instead, electrodes are placed at carefully selected acupoint locations to stimulate nerves in that region.
TEAS has been used as a treatment in reproductive health in China for many years. Several scientific studies show that these therapies improve pregnancy rates for women when used as an assisted reproductive technology.
For example, in a seminal study published in Fertility and Sterility, one of the most prestigious medical journals in reproductive medicine, researchers concluded that use of TEAS significantly increased the pregnancy rate for women who underwent embryo transfer.